Program
ISGCT 2026 Agenda
- - Welcome Address (Main Hall)
- - Keynote Lecture: Prof. Drew Weissman (Main Hall)
- - The RNA Revolution: from Vaccines to Therapeutic Genome Editing (Main Hall)
- - Cytokine armored CAR-T and TIL therapy (Main Hall)
- - In vivo engineering of T cells with AAV (Main Hall)
- - Overcoming Barriers: Enhancing CAR T-Cell Therapy Efficacy in brain tumors (Main Hall)
- - Retinitis Pigmentosa Caused by Mutations in the FAM161A Gene: Steps on the Path to Gene Therapy (Main Hall)
- - Brain-targeted lipid nanoparticles for neuronal gene therapy (Main Hall)
- - An Engager Platform for I n Vivo CAR T Cell Therapy, Gene Therapy, and Oncolytic Virotherapy (Main Hall)
- - Exosome platform: ExoPTEN as a novel therapy for nerve regeneration, and beyond (Main Hall)
- - Genetic therapy for hypertrophic cardiomyopathy. (Main Hall)
- - Development of an In-House KRAS Specific TCR-T Platform for Pancreatic Cancer Patients at Sheba Medical Center (Main Hall)
- - Trivalent Virus-Specific T cell Biobank enables rapid treatment of sever viral infections in immuncompromised patients (Main Hall)
- - AI-designed Immune Stimulator Armored Cell Therapy for Treatment of Solid Cancer (Main Hall)
- - Mitochondrial Augmentation as a Therapeutic Strategy in Bone Marrow Failure Disorders: From Pearson Syndrome to Myelodysplastic Syndrome (Main Hall)
- - Beyond the mutanome: Translation fidelity as a source of targetable tumor antigens (Main Hall)
- - Promise and challenges implementing TNFa signaling in engineered T cells (Main Hall)
- - Targeted genome editing for in vivo CAR T cell therapy (Main Hall)
- - AI-powered drug delivery: In-vivo CAR-T Program (Main Hall)
- - Decoding the structure-activity relationship of RNA delivery conjugates (Main Hall)
- - From Gene to Therapy: Translating WWOX Biology into a Gene Therapy for WOREE Syndrome (Main Hall)
- - Poster Awards & Closing Remarks (Main Hall)
ISGCT 2026 Posters Exhibition
- - Posters Exhibition (Exhibition Area)
